Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine + BUCY vs BUCY for TP53+ Myeloid Tumors
NCT04123392Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Oct 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT04123392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123392.